000286754 001__ 286754
000286754 005__ 20241106132744.0
000286754 0247_ $$2doi$$a10.3390/cancers16010202
000286754 0247_ $$2pmid$$apmid:38201629
000286754 0247_ $$2altmetric$$aaltmetric:158291016
000286754 037__ $$aDKFZ-2024-00086
000286754 041__ $$aEnglish
000286754 082__ $$a610
000286754 1001_ $$0P:(DE-He78)236d02bfaad255f19aa65e9cd9d63a8a$$aVlaski, Tomislav$$b0$$eFirst author$$udkfz
000286754 245__ $$aFrom a Clustering of Adverse Symptoms after Colorectal Cancer Therapy to Chronic Fatigue and Low Ability to Work: A Cohort Study Analysis with 3 Months of Follow-Up.
000286754 260__ $$aBasel$$bMDPI$$c2024
000286754 3367_ $$2DRIVER$$aarticle
000286754 3367_ $$2DataCite$$aOutput Types/Journal article
000286754 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1704980343_23910
000286754 3367_ $$2BibTeX$$aARTICLE
000286754 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000286754 3367_ $$00$$2EndNote$$aJournal Article
000286754 500__ $$a#EA:C070#LA:C070#
000286754 520__ $$aIn colorectal cancer (CRC) patients, apart from fatigue, psychological and physical symptoms often converge, affecting their quality of life and ability to work. Our objective was to ascertain symptom clusters within a year following CRC treatment and their longitudinal association with persistent fatigue and reduced work ability at the 3-month follow-up. We used data from MIRANDA, a multicenter cohort study enrolling adult CRC patients who are starting a 3-week in-patient rehabilitation within a year post-curative CRC treatment. Participants completed questionnaires evaluating symptoms at the start of rehabilitation (baseline) and after three months. We performed an exploratory factor analysis to analyze the clustering of symptoms at baseline. Longitudinal analysis was performed using a multivariable linear regression model with dichotomized symptoms at baseline as independent variables, and the change in fatigue and ability to work from baseline to 3-month-follow-up as separate outcomes, adjusted for covariates. We identified six symptom clusters: fatigue, gastrointestinal symptoms, pain, psychosocial symptoms, urinary symptoms, and chemotherapy side effects. At least one symptom from each factor was associated with higher fatigue or reduced ability to work at the 3-month follow-up. This study highlights the interplay of multiple symptoms in influencing fatigue and work ability among CRC patients post-rehabilitation.
000286754 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000286754 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000286754 650_7 $$2Other$$aability to work
000286754 650_7 $$2Other$$acolorectal cancer
000286754 650_7 $$2Other$$afatigue
000286754 650_7 $$2Other$$arehabilitation
000286754 650_7 $$2Other$$asymptom clusters
000286754 7001_ $$0P:(DE-He78)6ebb9642e577b54162be85ccb2e4941f$$aSlavic, Marija$$b1$$udkfz
000286754 7001_ $$aCaspari, Reiner$$b2
000286754 7001_ $$aBilsing, Bettine$$b3
000286754 7001_ $$aFischer, Harald$$b4
000286754 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$udkfz
000286754 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b6$$eLast author$$udkfz
000286754 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers16010202$$gVol. 16, no. 1, p. 202 -$$n1$$p202$$tCancers$$v16$$x2072-6694$$y2024
000286754 8564_ $$uhttps://inrepo02.dkfz.de/record/286754/files/cancers-16-00202.pdf
000286754 8564_ $$uhttps://inrepo02.dkfz.de/record/286754/files/cancers-16-00202.pdf?subformat=pdfa$$xpdfa
000286754 909CO $$ooai:inrepo02.dkfz.de:286754$$pVDB
000286754 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)236d02bfaad255f19aa65e9cd9d63a8a$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000286754 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6ebb9642e577b54162be85ccb2e4941f$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000286754 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000286754 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000286754 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000286754 9141_ $$y2024
000286754 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2022$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-07-31T16:07:06Z
000286754 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-07-31T16:07:06Z
000286754 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-07-31T16:07:06Z
000286754 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-07-31T16:07:06Z
000286754 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2022$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-26
000286754 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-26
000286754 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000286754 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000286754 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000286754 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000286754 980__ $$ajournal
000286754 980__ $$aVDB
000286754 980__ $$aI:(DE-He78)C070-20160331
000286754 980__ $$aI:(DE-He78)HD01-20160331
000286754 980__ $$aUNRESTRICTED